|
| Status |
Public on Oct 05, 2018 |
| Title |
Defining T cell states associated with response to checkpoint immunotherapy in melanoma |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
we profiled 16,291 immune cells from 48 tumor samples of melanoma patients treated with checkpoint inhibitors, using single-cell transcriptomics.
|
| |
|
| Overall design |
Tumors were disaggregated, sorted into CD45+ single cells, and profiled by Smart-seq2
-----------------------------------------------------
Submitter states "As this is human data, raw sequencing files are submitted via dbGap."
dbGaP accession code: phs001680.v1.p1
|
| |
|
| Contributor(s) |
Sade-Feldman M, Yizhak K |
| Citation(s) |
30388456 |
| |
| Submission date |
Sep 27, 2018 |
| Last update date |
Mar 26, 2019 |
| Contact name |
Keren Yizhak |
| E-mail(s) |
kyizhak@broadinstitute.org
|
| Organization name |
Broad Institute of MIT and Harvard
|
| Street address |
415 Main street
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02142 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (48)
|
|
| Relations |
| BioProject |
PRJNA493623 |
Less...
More...